Immune checkpoint therapy—current perspectives and future directions

P Sharma, S Goswami, D Raychaudhuri, BA Siddiqui… - Cell, 2023 - cell.com
Immune checkpoint therapy (ICT) has dramatically altered clinical outcomes for cancer
patients and conferred durable clinical benefits, including cure in a subset of patients …

Therapeutic targeting of tumour myeloid cells

ST Barry, DI Gabrilovich, OJ Sansom… - Nature Reviews …, 2023 - nature.com
Myeloid cells are pivotal within the immunosuppressive tumour microenvironment. The
accumulation of tumour-modified myeloid cells derived from monocytes or neutrophils …

Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression

A Sattiraju, S Kang, B Giotti, Z Chen, VJ Marallano… - Immunity, 2023 - cell.com
Glioblastoma (GBM), a highly lethal brain cancer, is notorious for immunosuppression, but
the mechanisms remain unclear. Here, we documented a temporospatial patterning of tumor …

The local microenvironment drives activation of neutrophils in human brain tumors

RR Maas, K Soukup, N Fournier, M Massara, S Galland… - Cell, 2023 - cell.com
Neutrophils are abundant immune cells in the circulation and frequently infiltrate tumors in
substantial numbers. However, their precise functions in different cancer types remain …

Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas

Y Ren, Z Huang, L Zhou, P Xiao, J Song, P He… - Nature …, 2023 - nature.com
Diffuse midline glioma-H3K27M mutant (DMG) and glioblastoma (GBM) are the most lethal
brain tumors that primarily occur in pediatric and adult patients, respectively. Both tumors …

Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma

H Liu, Q Zhao, L Tan, X Wu, R Huang, Y Zuo, L Chen… - Cancer cell, 2023 - cell.com
Malignant gliomas are largely refractory to immune checkpoint blockade (ICB) therapy. To
explore the underlying immune regulators, we examine the microenvironment in glioma and …

Brain macrophage development, diversity and dysregulation in health and disease

A Silvin, J Qian, F Ginhoux - Cellular & molecular immunology, 2023 - nature.com
Brain macrophages include microglia in the parenchyma, border-associated macrophages
in the meningeal-choroid plexus-perivascular space, and monocyte-derived macrophages …

Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages

D Croci, R Santalla Méndez, S Temme… - Science Translational …, 2022 - science.org
High-grade gliomas, the most common and aggressive primary brain tumors, are
characterized by a complex tumor microenvironment (TME). Among the immune cells …

CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment

J Wen, S Wang, R Guo, D Liu - European Journal of Medicinal Chemistry, 2023 - Elsevier
Abstract ABSTRACT: Colony-Stimulating Factor-1 Receptor (CSF1R) is a receptor tyrosine
kinase that controls the differentiation and maintenance of most tissue-resident …

Tumor-associated macrophages in gliomas—basic insights and treatment opportunities

JK Andersen, H Miletic, JA Hossain - Cancers, 2022 - mdpi.com
Simple Summary Macrophages are a specialized immune cell type found in both
invertebrates and vertebrates. Versatile in functionality, macrophages carry out important …